StockNews.com began coverage on shares of Cabot (NYSE:CBT – Get Rating) in a research report sent to investors on Thursday morning. The firm issued a buy rating on the specialty chemicals company’s stock. A number of other brokerages have also weighed in on CBT. JPMorgan Chase & Co. raised their price objective on Cabot from […]